Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ascot Hospital Pharmaceuticals was a pharmaceutical manufacturer that specialized in hospital-grade generic medications and parenteral products. Originally a subsidiary of the American Hospital Supply Corporation, the company became a division of Travenol Laboratories and was subsequently integrated into Baxter International following the 1985 merger of its parent companies. Based in Skokie, Illinois, its portfolio historically included essential treatments such as parenteral multivitamins, cardiovascular agents like isosorbide dinitrate, and sedatives such as hydroxyzine. While it is no longer an active independent operating entity, it remains recognized in regulatory records, appearing on FDA Generic Drug User Fee Amendments (GDUFA) lists due to its legacy Abbreviated New Drug Applications (ANDAs).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ascot Hosp Pharmaceuticals.